The Evolution of Systemic Microvascular Reactivity in Heart Transplant Patients
Launched by NATIONAL INSTITUTE OF CARDIOLOGY, LARANJEIRAS, BRAZIL · Feb 6, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how blood vessels respond in heart transplant patients over time. Researchers want to understand the way these small blood vessels work, which could help improve the care and evaluation of heart transplant patients. They are particularly interested in using a non-invasive test that looks at blood flow in the skin to provide additional information about a patient's heart health.
The trial is currently looking for participants aged between 18 and 75 who can understand the study and give their consent. However, those who are pregnant, have an active infection, or are using certain devices to assist with circulation cannot take part. If eligible, participants can expect to contribute to important research that may lead to better monitoring and treatment options for people who have received a heart transplant.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • capability to understand the objectives of the research and to fulfill the Term of Consent
- Exclusion Criteria:
- • Pregnancy, acute infection diagnosis, use of circulatory assistance devices
About National Institute Of Cardiology, Laranjeiras, Brazil
The National Institute of Cardiology (Instituto Nacional de Cardiologia) in Laranjeiras, Brazil, is a leading research institution dedicated to advancing cardiovascular health through innovative clinical trials and research initiatives. Renowned for its commitment to improving patient outcomes, the institute combines cutting-edge medical research with comprehensive patient care, focusing on the prevention, diagnosis, and treatment of cardiovascular diseases. With a multidisciplinary team of experts, the National Institute of Cardiology plays a pivotal role in shaping clinical practices and contributing to the global understanding of cardiovascular health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rio De Janeiro, , Brazil
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials